title: Treating hearing disorders with cell and  gene therapy.
abstract: Hearing loss is an increasing problem for a substantial number of people and, with an aging population, the incidence and severity of hearing loss will become more significant over time. There are very few therapies currently available to treat hearing loss, and so the development of new therapeutic strategies for hearing impaired individuals is of paramount importance to address this unmet clinical need. Most forms of hearing loss are progressive in nature and therefore an opportunity exists to develop novel therapeutic approaches to slow or halt hearing loss progression, or even repair or replace lost hearing function. Numerous emerging technologies have potential as therapeutic options. This paper details the potential of cell- and gene-based therapies to provide therapeutic agents to protect sensory and neural cells from various insults known to cause hearing loss; explores the potential of replacing lost sensory and nerve cells using gene and stem cell therapy; and describes the considerations for clinical translation and the challenges that need to be overcome.
authors.forename: Lisa N
authors.initials: LN
authors.lastname: Gillespie
authors.forename: Rachael T
authors.initials: RT
authors.lastname: Richardson
authors.forename: Bryony A
authors.initials: BA
authors.lastname: Nayagam
authors.forename: Andrew K
authors.initials: AK
authors.lastname: Wise
mesh_terms: D000818:Animals; D064987:Cell- and Tissue-Based Therapy / Q000379:methods / Q000639:trends*; D003051:Cochlea / Q000187:drug effects / Q000473:pathology; D016503:Drug Delivery Systems / Q000379:methods / Q000639:trends*; D015316:Genetic Therapy / Q000379:methods / Q000639:trends*; D034381:Hearing Loss / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D033581:Stem Cell Transplantation / Q000379:methods; D016896:Treatment Outcome